Molecular Therapy - Methods & Clinical Development

Slides:



Advertisements
Similar presentations
THE INNER EAR Two Sensory Divisions; one dedicated to hearing, the other to maintaining balance Vestibular Division - The balance organs - SC Canals -
Advertisements

Acoustic reflex Protective function Protective function Due to muscle contraction in response to intense sound Due to muscle contraction in response to.
ANATOMY OF THE EAR. Pinna External Auditory Meatus.
Tetrahydrocurcumin provides neuroprotection in rats after traumatic brain injury: autophagy and the PI3K/AKT pathways as a potential mechanism  Yongyue.
Assessment of murine colorectal cancer by micro-ultrasound using three dimensional reconstruction and non-linear contrast imaging  Jessica L Freeling,
Molecular Therapy - Methods & Clinical Development
Date of download: 10/26/2017 Copyright © ASME. All rights reserved.
Anatomy of the Sensorineural Mechanism
Copyright © American Speech-Language-Hearing Association
Anatomy of the Sensorineural Mechanism
A, Representation of the human inner ear
Sharen E. McKay, Wayne Yan, Jessica Nouws, Maximilian J
Volume 18, Issue 5, Pages (May 2010)
Increased Apoptosis, Altered Oxygen Signaling, and Antioxidant Defenses in First- Trimester Pregnancies with High-Resistance Uterine Artery Blood Flow 
Molecular Therapy - Methods & Clinical Development
Volume 5, Issue 6, Pages (June 2002)
Peripheral auditory mechanisms
Structure of the Inner Ear and Its Mechanical Response
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Volume 12, Issue 13, Pages (July 2002)
Volume 191, Issue 1, Pages (January 2014)
The Special Senses: Part D
Anders Fridberger, Jerker Widengren, Jacques Boutet de Monvel 
Wei Dong, Elizabeth S. Olson  Biophysical Journal 
Volume 25, Issue 2, Pages (February 2017)
Assessment of murine colorectal cancer by micro-ultrasound using three dimensional reconstruction and non-linear contrast imaging  Jessica L Freeling,
Volume 9, Issue 5, Pages (May 2004)
The cochlea Current Biology
Anatomy of the Sensorineural Mechanism
Qixu Zhang, Qing Chang, Robert A. Cox, Xuemei Gong, Lisa J. Gould 
Volume 77, Issue 1, Pages (January 2013)
Volume 20, Issue 6, Pages (December 2014)
Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy  Masahito Ikawa, Nobushige.
Transglutaminase 3 Protects against Photodamage
Volume 18, Issue 10, Pages (October 2010)
Molecular Therapy - Methods & Clinical Development
Volume 77, Issue 1, Pages (January 2013)
Molecular Therapy - Methods & Clinical Development
Molecular Therapy - Methods & Clinical Development
Volume 75, Issue 2, Pages (July 2012)
Fas and c-kit are Involved in the Control of Hair Follicle Melanocyte Apoptosis and Migration in Chemotherapy-Induced Hair Loss  Andrei A. Sharov, Guang-Zhi.
Volume 19, Issue 1, Pages (January 2011)
RNA Interference Prevents Autosomal-Dominant Hearing Loss
EphA4-ADAM10 Interplay Patterns the Cochlear Sensory Epithelium through Local Disruption of Adherens Junctions  Jean Defourny, Christiane Peuckert, Klas.
Volume 2, Issue 3, Pages (March 2014)
Detection of Cochlear Amplification and Its Activation
Sema4D, the Ligand for Plexin B1, Suppresses c-Met Activation and Migration and Promotes Melanocyte Survival and Growth  Joanne Soong, Yulin Chen, Elina.
Molecular Therapy - Methods & Clinical Development
Volume 25, Issue 11, Pages (November 2017)
Volume 5, Issue 6, Pages (June 2002)
Strong Promoters Are the Key to Highly Efficient, Noninflammatory and Noncytotoxic Adenoviral-Mediated Transgene Delivery into the Brain in Vivo  Christian.
Spatially and Temporally Regulated NRF2 Gene Therapy Using Mcp-1 Promoter in Retinal Ganglion Cell Injury  Kosuke Fujita, Koji M. Nishiguchi, Yukihiro.
Mouse Otocyst Transuterine Gene Transfer Restores Hearing in Mice With Connexin 30 Deletion-associated Hearing Loss  Toru Miwa, Ryosei Minoda, Momoko.
Molecular Therapy - Methods & Clinical Development
Donna M. Martin, Yehoash Raphael  Molecular Therapy 
Cochlear explant and slice preparation, and CDDP‐induced DNA damage and cell death in sensory hair cells and spiral ganglion neurons Cochlear explant and.
Molecular Therapy - Methods & Clinical Development
Prapasri Sinswat, Wei-Jing Wu, Su-Hua Sha, Jochen Schacht 
Kasey L Jackson, Robert D Dayton, Ronald L Klein 
Volume 6, Issue 3, Pages (September 2002)
Volume 14, Issue 3, Pages (September 2006)
Volume 26, Issue 5, Pages (May 2018)
Volume 24, Issue 1, Pages (January 2016)
Volume 11, Issue 2, Pages (August 2018)
Noise exposure increased p-LKB1 in the cochlea
Volume 18, Issue 5, Pages (May 2010)
Volume 9, Issue 2, Pages (February 2004)
Rumwald Leo G Lecaros, Leaf Huang, Tsai-Chia Lee, Yih-Chih Hsu 
Targeting expression of a transgene to the airway surface epithelium using a ciliated cell-specific promoter  Lawrence E Ostrowski, James R Hutchins,
Foxo3 is expressed in the adult mouse cochlea.
Presentation transcript:

Molecular Therapy - Methods & Clinical Development Protein transduction therapy into cochleae via the round window niche in guinea pigs  Hiroki Takeda, Takaomi Kurioka, Taku Kaitsuka, Kazuhito Tomizawa, Takeshi Matsunobu, Farzana Hakim, Kunio Mizutari, Toru Miwa, Takao Yamada, Momoko Ise, Akihiro Shiotani, Eiji Yumoto, Ryosei Minoda  Molecular Therapy - Methods & Clinical Development  Volume 3, (January 2016) DOI: 10.1038/mtm.2016.55 Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 1 Sectional images after enhanced green fluorescent protein (EGFP) or EGFP-9R transduction. (a) Cross-sectional diagram of a normal adult cochlea. The adult mammalian cochlea consists of three compartments: the scala vestibuli; scala tympani; and, scala media. The scala media contains the organ of Corti (OC). The OC contains inner hair cells (IHCs) and outer hair cells (OHCs). The IHCs and outer hair cells (OHCs) act as mechano-electrical transducers and play a crucial role in hearing. The electrical signal is transmitted via the spiral ganglion cells (SGC) to the auditory pathway of the brain. The stria vascularis (SV), located in the lateral wall of the scala media, is responsible for the secretion of K+ into the endolymph and the production of the endocochlear potential. (b) The images show sections of the middle turns of the cochleae. In the s-EGFP-9R group, EGFP was detectable strongly in the SV, OC and SGC at 12 hours. Also EGFP was detectable strongly in the SV, OC, and SGC, and slightly in the spiral limbus (SL) and the spiral ligament (SLg) 24 hours. EGFP levels were moderately detectable at the SV and SG at 48 hours and only slightly detectable at the SV at 72 hours. (c) At 24 hours in the s-EGFP-9R Group. EGFP was detectable at all turns in the cochlea. (d) At the middle turn of the cochleae in the s-EGFP group, EGFP was slightly detectable in the SGC at 12 hours and in the SV at 24 hours. (e) At the middle turn of the cochleae in the d-EGFP-9R group, EGFP was significantly detectable in the SV and SGC at 48 hours. The scale bars indicate 50 μm. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.55) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 2 Quantification of protein transduction levels via western blot. (a) GFP and β-actin protein expression was detected utilizing western blotting in the s-EGFP-9R and d-EGFP-9R groups. (b) Quantification of GFP protein transduction levels was performed utilizing the relative intensity. The relative intensity in s-EGFP-9R Group at 24 hours was significantly higher than that at 0 hours and at 24 hours in the s- enhanced green fluorescent protein (EGFP) groups. The EGFP transduction level at 48 hours in the d-EGFP-9R Group was significantly higher compared with that at 0 hours and that at 24 hours in the s-EGFP Group, while EGFP transduction level at 48 hours in the s-EGFP-9R Group indicates no significant change compared with that at 0 hours and that at 24 hours in the s-EGFP group. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.55) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 3 Quantification of protein transduction levels via mLI. (a) The mLIs in the s-EGFP, s-EGFP-9R and d-EGFP-9R groups are shown. The mLIs of the treated-side cochleae in the s-EGFP-9R Group peaked at 24 hours, decreased over time, and became approximately equal to that in 0 hours by 72 hours. (b) The mLIs at each turn at 24 hours in the s-EGFP-9R Group are shown. The mLI in the SV and SGC at the lower turns was generally higher, versus at the higher turns. Each n = 5. *P < 0.05; **P < 0.01. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.55) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 4 RWM thickness. (a) Typical sectional images of the round window membrane (RWM) at 24 hours in the s-EGFP-9R group. The RWM thickness in treated-side cochleae appears to be thicker than that in nontreated cochleae. Scale bars indicate 20 μm. ST: scala tympani; TC: tympanic cavity. (b) The thickness of the RWM in the s-EGFP-9R group. The thickness of the RWM in treated-side cochleae was significantly greater than that in nontreated cochleae in the s-EGFP-9R group. Each n = 5. **P < 0.01. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.55) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 5 Chronologicanl changes of XIAP protein expression levels. (a) Representative western blot results showing the transduction levels of X-linked inhibitor of apoptosis protein (XIAP) in the whole cochleae. (b) Quantification of the transduction levels of XIAP in the cochleae. The transduction levels for XIAP in s-XIAP-9R-treated cochleae were significantly higher than those in XIAP-treated cochleae at 12 and 24 hours. Each n = 4. *P < 0.05. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.55) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 6 ABR testing results at 14 days after noise exposure. A significant difference was found between the s-XIAP-9R and saline groups at 32 kHz. *P < 0.05. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.55) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions

Figure 7 XIAP experiment results. (a) Quantification of outer hair cells (OHC) loss at each frequency region at 14 days after treatment is shown. OHC loss at the 32-kHz region in the S-XIAP-9R group was significantly lower than that in the saline group. Each n = 5. *P < 0.05. (b) Surface preparations from the basal turns of cochleae at 2 days after noise exposure. TUNEL-positive nuclei are indicated by white arrowheads. IHCs: inner hair cells. 1, 2, and 3: first, second, and third rows of OHCs. The scale bar indicates 10 μm. (c) Quantification of TUNEL-positive cells in the 32-kHz region. The number of TUNEL-positive cells in the s-XIAP-9R group was significantly lower than that in the saline group. Each n = 5. *P < 0.05. (d) Surface preparations of the 32-kHz region of a cochlea at 1 day after noise exposure. Cleaved caspase-3-positive cells are indicated by white arrowheads. 1, 2, and 3: first, second, and third rows of OHCs. The scale bar indicates 10 μm. (e) Quantification of cleaved caspase-3-positive OHCs from the basal regions. The number of cleaved caspase-3-positive OHCs in the s-XIAP-9R group was significantly lower than that in the saline group. Each n = 5. *P < 0.05. Molecular Therapy - Methods & Clinical Development 2016 3, DOI: (10.1038/mtm.2016.55) Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy Terms and Conditions